Yareni Gutierrez-Gomez1,2, Aryeh D Stein3, Usha Ramakrishnan3, Albino Barraza-Villarreal4, Hortensia Moreno-Macias5, Carlos Aguilar-Salinas6, Isabelle Romieu7, Juan A Rivera8. 1. Center for Nutrition and Health Research and. 2. Department of Nutrition, Instituto Tecnológico y de Estudios Superiores de Monterrey (Monterrey Institute of Technology and Higher Education), Mexico City, Mexico. 3. Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA. 4. Center for Population Health Research, Instituto Nacional de Salud Pública (National Institute of Public Health), Cuernavaca, Mexico. 5. Universidad Autónoma Metropolitana (Metropolitan Autonomous University), Mexico City, Mexico. 6. Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (National Institute of Medical Science and Nutrition Salvador Zubiran), Mexico City, Mexico; and. 7. Nutritional Epidemiology Department, International Agency for Research on Cancer, Lyon, France. 8. Center for Nutrition and Health Research and jrivera@insp.mx.
Abstract
BACKGROUND:Docosahexaenoic acid (DHA) has regulatory effects on lipid and glucose metabolism. Differences in DHA availability during specific developmental windows may program metabolic changes. OBJECTIVE: We investigated the effects of maternal DHA supplementation during pregnancy on the nonfasting serum lipid and glucose concentrations of offspring at 4 y of age. METHODS: We used data from the Prenatal Omega-3 Fatty Acid Supplementation, Growth, and Development trial, a double-blind randomized controlled trial conducted in Mexico. Pregnant women were supplemented daily with 400 mg DHA or placebo from 18-22 wk of gestation to delivery. The primary outcomes of the trial were offspring growth and neurological development. Nonfasting blood samples were obtained from the offspring at 4 y of age. We analyzed serum total, HDL, non-HDL, and LDL cholesterol; the total-to-HDL cholesterol ratio; apolipoprotein B (apoB); triglycerides; glucose; and insulin as secondary outcomes and compared their concentrations between treatment groups. RESULTS: Data from 524 offspring were available. The women were compliant with the intervention based on pill counts and changes in cord blood and breast milk DHA concentrations. None of the between-group differences (DHA compared with placebo), adjusted for maternal height and time since last food intake, were significant (P range 0.27-0.83). Means (95% CIs) were as follows: total cholesterol (TC), 1.73 mg/dL (-2.63, 6.09 mg/dL); HDL cholesterol, 0.66 mg/dL (-1.07, 2.39 mg/dL); non-HDL cholesterol, 1.77 mg/dL (-1.83, 5.37 mg/dL); LDL cholesterol, 1.62 mg/dL (-2.21, 5.45 mg/dL); TC:HDL ratio, 0.01 (-0.09, 0.11); apoB, -0.15 mg/dL (-2.78, 2.48 mg/dL); triglycerides, 0.21 mg/dL (-10.93, 10.52 mg/dL); glucose, -0.67 mg/dL (-2.46, 1.11 mg/dL); and insulin, 0.62 μU/mL (-0.88, 2.11 μU/mL). CONCLUSION:Prenatal DHA supplementation does not affect nonfasting serum lipid and glucose concentrations of offspring at 4 y of age. This trial was registered at clinicaltrials.gov as NCT00646360.
RCT Entities:
BACKGROUND:Docosahexaenoic acid (DHA) has regulatory effects on lipid and glucose metabolism. Differences in DHA availability during specific developmental windows may program metabolic changes. OBJECTIVE: We investigated the effects of maternal DHA supplementation during pregnancy on the nonfasting serum lipid and glucose concentrations of offspring at 4 y of age. METHODS: We used data from the Prenatal Omega-3 Fatty Acid Supplementation, Growth, and Development trial, a double-blind randomized controlled trial conducted in Mexico. Pregnant women were supplemented daily with 400 mg DHA or placebo from 18-22 wk of gestation to delivery. The primary outcomes of the trial were offspring growth and neurological development. Nonfasting blood samples were obtained from the offspring at 4 y of age. We analyzed serum total, HDL, non-HDL, and LDL cholesterol; the total-to-HDL cholesterol ratio; apolipoprotein B (apoB); triglycerides; glucose; and insulin as secondary outcomes and compared their concentrations between treatment groups. RESULTS: Data from 524 offspring were available. The women were compliant with the intervention based on pill counts and changes in cord blood and breast milk DHA concentrations. None of the between-group differences (DHA compared with placebo), adjusted for maternal height and time since last food intake, were significant (P range 0.27-0.83). Means (95% CIs) were as follows: total cholesterol (TC), 1.73 mg/dL (-2.63, 6.09 mg/dL); HDL cholesterol, 0.66 mg/dL (-1.07, 2.39 mg/dL); non-HDL cholesterol, 1.77 mg/dL (-1.83, 5.37 mg/dL); LDL cholesterol, 1.62 mg/dL (-2.21, 5.45 mg/dL); TC:HDL ratio, 0.01 (-0.09, 0.11); apoB, -0.15 mg/dL (-2.78, 2.48 mg/dL); triglycerides, 0.21 mg/dL (-10.93, 10.52 mg/dL); glucose, -0.67 mg/dL (-2.46, 1.11 mg/dL); and insulin, 0.62 μU/mL (-0.88, 2.11 μU/mL). CONCLUSION: Prenatal DHA supplementation does not affect nonfasting serum lipid and glucose concentrations of offspring at 4 y of age. This trial was registered at clinicaltrials.gov as NCT00646360.
Authors: Børge G Nordestgaard; Anne Langsted; Samia Mora; Genovefa Kolovou; Hannsjörg Baum; Eric Bruckert; Gerald F Watts; Grazyna Sypniewska; Olov Wiklund; Jan Borén; M John Chapman; Christa Cobbaert; Olivier S Descamps; Arnold von Eckardstein; Pia R Kamstrup; Kari Pulkki; Florian Kronenberg; Alan T Remaley; Nader Rifai; Emilio Ros; Michel Langlois Journal: Clin Chem Date: 2016-05-27 Impact factor: 8.327
Authors: Renate Lucia Bergmann; Karl E Bergmann; Elisabeth Haschke-Becher; Rolf Richter; Joachim W Dudenhausen; Denis Barclay; Ferdinand Haschke Journal: J Perinat Med Date: 2007 Impact factor: 1.901
Authors: Maria del Mar Bibiloni; Rogelio Salas; Hilda I Novelo; Jesús Z Villarreal; Antoni Sureda; Josep A Tur Journal: PLoS One Date: 2015-03-20 Impact factor: 3.240
Authors: Sirazul Ameen Sahariah; Meera Gandhi; Harsha Chopra; Sarah H Kehoe; Matthew J Johnson; Chiara di Gravio; Deepak Patkar; Harshad Sane; Patsy J Coakley; Aarti H Karkera; Dattatray S Bhat; Nick Brown; Barrie M Margetts; Alan A Jackson; Kalyanaraman Kumaran; Ramesh D Potdar; Caroline H D Fall Journal: J Nutr Date: 2022-04-01 Impact factor: 4.798